AstraZeneca gives first doses to patients in Covid-19 treatment trial

Pharmaceutical giant AstraZeneca has said the first volunteers have now been dosed in its clinical trial of a new drug to help prevent and treat Covid-19. Picture: PA

Pharmaceutical giant AstraZeneca has said the first volunteers have now been dosed in its clinical trial of a new drug to help prevent and treat Covid-19.

The group, which is also separately developing a Covid-19 vaccine together with scientists at Oxford University, said the drug – known as AZD7442 – is a combination of two monoclonal antibodies.